Exicure Inc

Healthcare · Biotechnology

1.20$ -0.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Exicure Inc (XCUR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 11 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet XCUR
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	–	21	11	11	25	29	24	19	36	29	25	20	74	115	106	96	111	100	88	74	78	65	42	37	29	23	24	18	13	12	11	11	11	15	21	19	15	14	13	11
Current Assets	–	20	20	10	24	28	23	18	34	28	24	19	72	113	102	89	97	86	74	61	64	44	29	25	17	10	11	3.7	3.1	2.0	1.5	2.1	2.6	14	11	8.6	5.4	4.6	3.5	2.3
Cash	–	20	-20	8.8	23	26	21	16	32	26	22	17	70	48	25	17	31	33	34	43	52	35	24	21	16	8.6	10.0	2.3	0.9	0.8	0.4	0.5	0.3	13	10	7.9	4.4	3.7	2.6	1.7
Cash & Short-Term Investments	–	20	20	8.8	23	26	21	16	32	26	22	17	70	111	99	86	94	82	67	56	61	39	26	22	16	8.6	–	2.3	–	–	0.4	0.5	0.3	13	10	7.9	4.4	3.7	2.6	1.7
Receivables	–	0.0	0.5	0.5	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.4	0.0	0.2	0.0	0.0	0.0	–	–	–	0.1	–	–	–	–	0.0	0.8	1.4	0.5	0.2	0.1	0.1	0.1	0.1	0.0
Inventory	–	–	–	0.0	–	–	–	0.0	0.0	0.6	0.8	0.9	0.7	1.3	1.6	2.4	1.3	3.0	5.0	3.6	2.2	–	–	–	–	0.5	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Property, Plant & Equipment	–	–	–	–	1.1	1.3	1.3	1.2	1.1	1.1	1.5	1.5	2.0	2.5	2.6	4.5	13	4.1	4.1	12	12	12	11	11	10	9.8	9.4	8.7	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.0	3.3	3.3	3.3	4.4	4.4	4.4
Intangible Assets	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	3.8	3.8	3.8	3.8	3.8	3.8
Total Liabilities	–	18	14	14	14	9.0	8.0	9.4	10	7.8	9.0	8.9	8.9	35	20	14	38	39	38	38	64	54	39	36	33	8.4	9.3	7.9	8.5	8.5	8.5	9.1	9.1	8.3	9.3	9.9	8.3	10	11	10
Current Liabilities	–	12	11	11	11	3.4	3.0	4.3	9.3	2.0	8.2	8.1	8.3	31	20	14	13	14	13	13	22	34	21	20	26	1.6	2.7	1.4	2.2	2.5	2.7	3.4	3.7	3.1	3.9	4.6	2.8	3.9	4.5	4.2
Short-Term Debt	–	1.2	2.5	2.5	2.6	4.9	0.8	1.6	4.9	–	5.0	5.1	5.2	5.3	0.3	0.2	0.2	0.2	0.3	0.4	0.4	7.3	0.5	0.5	0.5	0.5	–	0.6	–	–	0.7	1.7	0.7	0.7	0.6	0.5	0.3	0.2	0.0	–
Accounts Payable	–	0.5	2.0	2.0	2.4	1.0	1.0	1.0	1.3	0.5	0.8	0.9	1.1	1.8	3.4	1.5	2.0	1.9	3.0	2.3	2.5	3.4	1.9	1.6	0.9	0.4	0.5	0.3	0.9	1.6	1.8	1.6	1.3	1.0	1.2	1.8	1.3	1.7	2.4	2.2
Long-Term Debt	–	–	–	–	2.7	4.9	4.1	3.3	–	4.9	0.4	–	–	–	–	–	17	17	17	17	17	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Shareholders' Equity	–	2.4	2.6	-3.2	12	20	16	9.9	25	21	16	11	65	81	85	82	73	62	50	37	14	11	3.2	1.2	-3.7	15	15	9.7	4.5	3.0	2.2	1.6	1.5	6.8	11	8.9	6.9	3.9	2.1	1.0
Retained Earnings	–	-23	-29	-29	-32	-34	-38	-45	-50	-55	-60	-66	-71	-81	-80	-84	-93	-106	-118	-133	-156	-170	-178	-186	-191	-173	-177	-183	-188	-190	-190	-191	-192	-199	-196	-199	-201	-204	-206	-207
Shares Outstanding	1.3	1.3	1.3	1.3	1.3	1.3	1.3	1.3	1.4	1.5	1.5	1.5	2.2	2.6	2.9	2.9	2.9	2.9	2.9	2.9	2.9	3.0	4.0	4.5	5.0	5.0	8.4	8.4	1.7	1.7	8.7	8.7	7.3	6.0	6.2	6.3	6.3	6.3	6.4	6.4

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings